[Form 4] Exponent Inc Insider Trading Activity

Rhea-AI Filing Summary

Joseph Sala, Group Vice President at Exponent Inc (EXPO), reported the sale of 1,595 shares of common stock on 08/12/2025 at a price of $70.6406 per share. The Form 4 discloses this Section 16 transaction and shows reported beneficial ownership of 0 shares following the sale. No derivative securities or additional transactions are listed on the form, and no explanatory detail is provided within the filing.

Insights

Financial Analyst

TL;DR: Officer sale of 1,595 shares reported; transaction size and filing suggest limited immediate market impact.

The Form 4 documents a direct sale of 1,595 common shares by Joseph Sala at $70.6406 per share on 08/12/2025, with reported beneficial ownership reduced to zero. The filing lists no derivative activity. Absent further context—such as patterns of ongoing sales, 10b5-1 plan disclosure, or material company developments—this single disposition appears routine and unlikely to be material to Exponent's equity valuation on its own.

Corporate Governance Expert

TL;DR: Form 4 appears to be a standard insider disclosure of an officer sale, fulfilling Section 16 reporting obligations.

The filing identifies Joseph Sala as Group Vice President and reports a sale of 1,595 shares. The document contains the required reporting fields and shows no listed derivative transactions. From a governance and compliance perspective, the Form 4 provides the mandated transparency on officer trading; the filing does not include additional governance concerns such as amendments, related-party transactions, or contested disclosures.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sala Joseph

(Last) (First) (Middle)

149 COMMONWEALTH DRIVE

(Street)

MENLO PARK CA 94025

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EXPONENT INC [ EXPO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Group Vice President

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/12/2025		S		1,595	D	$70.6406	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	By: Wendy Whitehouse For: Joseph Sala	08/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did the Form 4 for EXPO report?

The Form 4 reports a sale of 1,595 shares of Exponent Inc common stock by Joseph Sala.

When was the EXPO insider transaction executed?

The reported transaction date is 08/12/2025.

At what price were the EXPO shares sold?

The sale price reported on the form is $70.6406 per share.

What was Joseph Sala's beneficial ownership after the sale according to the filing?

The Form 4 shows reported beneficial ownership of 0 shares following the transaction.

Did the Form 4 list any derivative transactions for EXPO?

No. The filing lists no derivative securities acquired, disposed of, or beneficially owned.